| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Doyle Mittie is a Chief Medical Officer at AVTX. Recent filings cover 0 purchases and 17 sales. Those positions are worth an estimated $1.0M at current prices.
Doyle Mittie's largest disclosed position is in AVTX as Chief Medical Officer, worth about $1.0M. The recent filings there lean toward selling, a net 151,516 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 679 | $20.00 | $13,580.00 | -1.3% | - | - | |
| Aug 17, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,000 | $20.00 | $20,000.00 | -1.9% | - | - | |
| Aug 10, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 679 | $20.00 | $13,580.00 | -1.3% | - | - | |
| Jul 27, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,000 | $20.00 | $20,000.00 | -1.9% | -64.5% | - | |
| Jun 30, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 4,654 | $20.00 | $93,080.00 | -8.2% | -18.4% | - | |
| Jun 23, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 1,450 | $18.00 | $26,100.00 | -2.7% | -9.3% | - | |
| May 28, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 679 | $16.00 | $10,864.00 | -1.4% | +27.4% | - | |
| May 15, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 3,000 | $18.76 | $56,280.00 | -45.3% | +9.6% | - | |
| May 6, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 108,234 | $20.61 | $2,230,366.60 | -96.8% | -15.0% | - | |
| Apr 6, 2026 | AVTX Avalo Therapeutics, Inc. | Chief Medical Officer | Sale+OE | 3,970 | $18.01 | $71,508.43 | -52.3% | +22.7% | - |